Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Sulforaphane glucosinolate, a compound found in cruciferous vegetables like broccoli, has attracted scientific interest for its potential neuroprotective properties, particularly in the context of neurodegenerative diseases such as Parkinson's Disease (PD). The scientific rationale for its use is based primarily on preclinical (cellular and animal) studies rather than clinical trials in humans. Sulforaphane is an indirect antioxidant, known to activate the Nrf2 pathway, which regulates the expression of a variety of cytoprotective and antioxidant enzymes. Activation of this pathway is believed to help mitigate oxidative stress, a key factor in the pathogenesis of PD. Several animal studies have demonstrated that sulforaphane administration can protect dopaminergic neurons from toxin-induced degeneration, a key feature of PD models. Sulforaphane has also been shown to reduce neuroinflammation and improve mitochondrial function in these models. However, despite these promising preclinical results, there is currently a lack of robust clinical trial data in humans with Parkinson’s Disease. Most evidence remains preliminary, and its translation to clinical practice is not yet established. In summary, while sulforaphane glucosinolate is not traditionally used for PD, there is a scientific basis—rooted in laboratory research—for exploring its use in this context. The evidence supporting its efficacy in humans is limited at this time, justifying a modest evidence rating.

More about sulforaphane glucosinolate
More about Parkinson's Disease

Other ingredients used for Parkinson's Disease

Other health conditions supported by sulforaphane glucosinolate

Products containing sulforaphane glucosinolate

Thorne Crucera-SGS